Insulet (PODD) Convertible Debt (2010 - 2011)

Insulet's (PODD) quarterly Convertible Debt came in at $106.3 million in Q3 2011, up 2.06% on a QoQ basis from $104.2 million in Q2 2011.

Insulet (PODD) Convertible Debt (2010 - 2011) Analysis & Trends

Insulet (PODD) has 2 years of Convertible Debt data on file, last reported at $106.3 million in Q3 2011.

Quarterly Convertible Debt changed N/A year-over-year to $106.3 million in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $106.3 million (changed N/A YoY) and the FY2010 annual result came in at $69.4 million, changed N/A from the prior year.
Convertible Debt advanced to $106.3 million in Q3 2011, from $104.2 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $106.3 million in Q3 2011 to a low of $69.4 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn
10	Insulet	10.34 Bn	9.81 Bn	562.60 Mn

Download Data